German firm accused of data breach

It's being called one of the biggest data scandals the German healthcare industry has ever seen. Munich area market research firm Pharmafakt GFD is being accused of selling raw prescription information to drug companies without removing data that can be used to trace identities.

Based on a confession, given “under oath,” and appearing in the magazine Der Spiegel, a former Pharmafakt employee says the datamining company saved data from millions of pharmacy prescriptions, analyzed them and then sold the records to pharma firms, without de-identifying them first.

The research outfit balked at the accusations: “The GFD did not pass on or sell personal data. All data is only used to produce studies,” Pharmafakt GFD manager Dietmar Wassener told the Süddeutsche Zeitung. A state enforcement official who was shown the Pharmafakt data, however, said it seemed authentic.

Clients of Pharmafakt GFD  include several top-10 drug­makers.
You must be a registered member of MMM to post a comment.

Email Newsletters


As US pharma continued its quest for a Grand Prix at the Lions Health international festival of creativity, MM&M went on location to Cannes, France. Missed our coverage from June? Now, we're giving you an opportunity to catch up on some of what you missed. Download our e-book on the two-day festival, recapping the event, rounding up the best of the speakers, offering perspective and listing all of the winners. Click here to download.


The most recent MM&M Skill Sets Live event surveyed a range of issues relating to one of the hottest promotional spaces in healthcare. Speakers and panelists at the morning-long session, including promotional- and multichannel-minded executives from GSK, Epocrates, Treato and Montefiore Medical Center, weighed in on topics designed to help marketers demystify the challenges associated with non-personal promotion. Click here.